The V Foundation
Victory Over Cancer®
The V Foundation
EIN: 13-3705951
Programs and results
Reports and documents
Download annual reportsWhat we aim to solve
The V Foundation is working to achieve Victory Over Cancer® by funding game-changing research and all-star scientists.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Cancer Research
The V Foundation for Cancer Research currently awards five types of grants.
V Scholar Grant: Three-year grant of $200,000 per year. It supports young tenure-track faculty by funding projects that are either laboratory-based fundamental research or translational research.
Translational Grant: Four-year grant of $200,000 per year. These grants support “bench to bedside” research, whose endpoint is often planning or initiation of a clinical trial.
All-Star Grant: Re-investment in previous V Scholar or Translational grant recipients who are invited to apply for a $1,000,000 grant payable over 5 years. Any type of cancer research is permitted.
Designated Grant: Supports basic or translational research at research institutions and may support outstanding research outside our standing list of NCI-Designated cancer centers. To trigger a new stand-alone grant opportunity, $3,000,000 must be raised.
Mission Grant: Supports educational projects (ex: increase clinical trial enrollment).
Where we work
Our results
How does this organization measure their results? It's a hard question but an important one.
Total number of grants awarded
This metric is no longer tracked.Totals By Year
Related Program
Cancer Research
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Total dollar amount of grants awarded
This metric is no longer tracked.Totals By Year
Related Program
Cancer Research
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Our Sustainable Development Goals
Learn more about Sustainable Development Goals.
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
The V Foundation is working to achieve Victory Over Cancer® by funding game-changing research and all-star scientists.
What are the organization's key strategies for making this happen?
The V Foundation is well-positioned to fund game-changing research and all-star scientists to accelerate Victory Over Cancer® due to the following key elements of who we are:
• 100% of direct donations go to all types of cancer research and programs. An endowment covers
administrative expenses.
• Donations go to the best and brightest scientists, from all backgrounds who are researching all
types of cancer. How do we find the best and brightest? Through our world-renowned Scientific Advisory
Committee (comprised of the nation's top doctors and scientists) that reviews and recommends the best
proposals for funding submitted from the 72 National Cancer Institute designated cancer centers and
other exceptional institutions across North America.
• Not only do we fund the best – we are the best stewards of your dollars. The V Foundation has received
11 consecutive 4-star ratings (out of 4) from Charity Navigator, a leading charity evaluator, placing us
among the top 2% of charities evaluated.
• These three facts work to support our mission - We fund game-changing research and all-star scientists to
accelerate Victory Over Cancer® and save lives.
• Our vision: Victory Over Cancer®
What are the organization's capabilities for doing this?
Leadership – The V Foundation's board of directors is comprised of prominent business leaders, award-winning athletes and coaches, distinguished physicians and outstanding journalists and entertainers. Board members serve on a volunteer basis and provide their expertise for the strategic leadership and governance of the Foundation.
Scientific Advisory Committee – The service of the V Foundation's preeminent and dedicated Scientific Advisory Committee ensures that the Foundation is strategic in its grant-making and only funds the best of the best research proposals. The Scientific Advisory Committee has worked with staff to construct a comprehensive grant evaluation program to measure the impact of past grants on scientific progress.
Corporate Partnerships – The V Foundation works with several corporate partners, including our founding partner ESPN, who use their substantial resources to spread the word of the Foundation's mission and to expose it to potential new donors.
Staff – As the V Foundation has grown in stature and significance in recent years, the staff has likewise grown to support its increased operations. Staff and other administrative costs are covered by the Foundation's endowment.
What have they accomplished so far and what's next?
The V Foundation, since its founding, has awarded more than $310 million in grants to support cancer research. Even more impressive is that these investments has directly leveraged an additional $1 billion+ in funding for cancer research.
These grants, however, are not only about quantity, but also quality. Because of the exclusivity and flexibility of the V Foundation's funding mechanisms, the Foundation has been able to fund the most promising and most needed cancer research projects. Further, the V Foundation has remained true to its support of collaborative efforts and has emphasized shared knowledge and partnerships whenever possible.
By funding the best and brigtest scientists, the V Foundation is accelerating the pace of progress. The cancer death rate has fallen by 33% since 1991, but there is more work to do. With its continued focus on research outcomes and responsible stewardship, the V Foundation has remained committed to its goal of providing hope and saving more lives through cancer research
Financials
Financial documents
Download audited financialsRevenue vs. expenses: breakdown
Liquidity in 2023 info
1.89
Months of cash in 2023 info
7.3
Fringe rate in 2023 info
24%
Funding sources info
Assets & liabilities info
Financial data
The V Foundation
Balance sheetFiscal Year: Oct 01 - Sep 30
The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Fiscal Year: Oct 01 - Sep 30
This snapshot of The V Foundation’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.
Created in partnership with
Business model indicators
Profitability info | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Unrestricted surplus (deficit) before depreciation | -$7,668,028 | $13,303,437 | $11,687,553 | -$6,564,145 | $5,935,255 |
As % of expenses | -23.2% | 70.9% | 44.1% | -19.9% | 11.8% |
Unrestricted surplus (deficit) after depreciation | -$7,754,898 | $13,213,436 | $11,587,143 | -$6,673,923 | $5,828,742 |
As % of expenses | -23.4% | 70.0% | 43.6% | -20.2% | 11.6% |
Revenue composition info | |||||
---|---|---|---|---|---|
Total revenue (unrestricted & restricted) | $33,522,505 | $19,512,235 | $32,236,754 | $38,304,202 | $47,813,363 |
Total revenue, % change over prior year | -16.4% | -41.8% | 65.2% | 18.8% | 24.8% |
Program services revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Membership dues | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Investment income | 5.4% | 5.4% | 3.1% | 3.9% | 4.9% |
Government grants | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
All other grants and contributions | 94.9% | 90.7% | 90.3% | 95.6% | 94.6% |
Other revenue | -0.4% | 3.9% | 6.6% | 0.5% | 0.5% |
Expense composition info | |||||
---|---|---|---|---|---|
Total expenses before depreciation | $33,042,754 | $18,773,498 | $26,494,141 | $32,960,232 | $50,301,280 |
Total expenses, % change over prior year | 7.1% | -43.2% | 41.1% | 24.4% | 52.6% |
Personnel | 9.3% | 19.0% | 12.3% | 11.8% | 9.2% |
Professional fees | 1.3% | 2.3% | 1.5% | 2.2% | 1.9% |
Occupancy | 0.3% | 0.7% | 0.6% | 0.3% | 0.3% |
Interest | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Pass-through | 84.0% | 70.6% | 81.2% | 79.9% | 82.9% |
All other expenses | 5.1% | 7.4% | 4.4% | 5.8% | 5.7% |
Full cost components (estimated) info | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Total expenses (after depreciation) | $33,129,624 | $18,863,499 | $26,594,551 | $33,070,010 | $50,407,793 |
One month of savings | $2,753,563 | $1,564,458 | $2,207,845 | $2,746,686 | $4,191,773 |
Debt principal payment | $0 | $0 | $0 | $0 | $0 |
Fixed asset additions | $0 | $0 | $0 | $0 | $0 |
Total full costs (estimated) | $35,883,187 | $20,427,957 | $28,802,396 | $35,816,696 | $54,599,566 |
Capital structure indicators
Liquidity info | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Months of cash | 8.3 | 12.9 | 12.0 | 5.3 | 7.3 |
Months of cash and investments | 21.1 | 37.0 | 31.3 | 25.6 | 21.8 |
Months of estimated liquid unrestricted net assets | 1.7 | 11.5 | 13.5 | 8.4 | 6.9 |
Balance sheet composition info | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Cash | $22,960,219 | $20,216,462 | $26,450,890 | $14,626,496 | $30,710,288 |
Investments | $35,014,646 | $37,604,040 | $42,647,621 | $55,776,973 | $60,499,329 |
Receivables | $16,343,005 | $5,962,058 | $6,674,241 | $7,340,786 | $6,264,235 |
Gross land, buildings, equipment (LBE) | $2,173,967 | $2,217,433 | $2,222,670 | $2,320,416 | $2,392,981 |
Accumulated depreciation (as a % of LBE) | 16.5% | 20.3% | 24.3% | 28.1% | 31.7% |
Liabilities (as a % of assets) | 47.9% | 36.8% | 34.6% | 37.4% | 48.9% |
Unrestricted net assets | $6,594,710 | $19,808,146 | $31,395,289 | $24,721,366 | $30,550,108 |
Temporarily restricted net assets | $21,070,870 | N/A | N/A | N/A | N/A |
Permanently restricted net assets | $12,138,934 | N/A | N/A | N/A | N/A |
Total restricted net assets | $33,209,804 | $21,967,524 | $19,510,294 | $25,196,735 | $20,373,654 |
Total net assets | $39,804,514 | $41,775,670 | $50,905,583 | $49,918,101 | $50,923,762 |
Key data checks
Key data checks info | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Material data errors | No | No | No | No | No |
Operations
The people, governance practices, and partners that make the organization tick.
Documents
Chief Executive Officer
Shane Jacobson
Shane Jacobson is the Chief Executive Officer of the V Foundation. He is an accomplished foundation executive with experience leading record-setting campaigns that align philanthropic partnerships with ambitious goals. At the V Foundation, Jacobson and the staff have a laser-sharp focus on funding game-changing research and all-star scientists to accelerate victory over cancer and save lives.
Prior to joining the organization, Jacobson served as the President & CEO of the University of Vermont Foundation. His team set an all-time high in fundraising through a highly successful $581 million campaign. Included in this total is nearly $300 million in support of academic medicine and patient care, as well as $43 million for athletics. They also generated substantial investments in research and scientific discovery by more than doubling the number of endowed faculty professorships and chairs, with more than 125 positions now at the University.
Number of employees
Source: IRS Form 990
The V Foundation
Officers, directors, trustees, and key employeesSOURCE: IRS Form 990
Compensation data
The V Foundation
Highest paid employeesSOURCE: IRS Form 990
Compensation data
The V Foundation
Board of directorsas of 07/27/2023
Board of directors data
Mr. Evan Goldberg
Jim Allegro
ESPN, Inc.
Robert C Bast, Jr., M.D.
M.D. Anderson Cancer Center
George Bodenheimer
ESPN, Inc.
Steven M Bornstein
NFL Network
Julie Maples
Fyrfly Venture Partners
George W Dennis III
Teague Campbell Dennis & Gorham, LLP
Michael W Krzyzewski
Duke University
Carl Liebert III
Keller Williams
Michael C MacDonald
Medifast
Geoffrey S Mason
Mainstay Communications
Joseph O Moore, M.D.
Duke Raleigh Cancer Center, Duke Raleigh Hospital
Lawrence F Probst III
Electronic Arts
Harry E. Rhoads, Jr.
Washington Speakers Bureau - Chief Executive Officer
Pamela Valvano Strasser
The V Foundation for Cancer Research
Nicholas P Valvano
The V Foundation for Cancer Research
Robert Valvano
ESPN, Inc.
Dick Vitale
ESPN, Inc. and ABC Sports
R.C. "Bucky" Waters
Duke University Medical Center - Retired Vice Chancellor for Special Projects; ESPN, Inc. & Madison Square Garden - Sports Commentator
Dereck Whittenburg
NC State University
David W. Williams
Whirlpool Corporation
David Fay
U.S. Golf Association
F.J. "Joe" Loughrey
Cummins, Inc.
Robert C. Nakasone
Toys "R" Us
Donna Orender
Orender Unlimited LLC
Constance E. Skidmore
PwC, LLP
Norby Williamson
ESPN, Inc.
Larry Woodard
Graham Stanley Advertising
Kevin Plank
Under Armour
Evan Goldberg
Oracle NetSuite Global Business Unit
Stuart Taylor
The Taylor Group
Mark King
Taco Bell
Jeff Berry
CAA Sports
Jay Bilas
Moore & Van Allen
Julie Chase
ChasePR
Nancy Davidson
Fred Hutchinson Cancer Research Center
Rita Ferro
Disney, Media & Entertainment
Matt Hong
Turner Sports
Michael B. Kastan, M.D., Ph.D.
Duke Cancer Institute
Clark Kinlin
Corning Optical Communications
William Nelson, M.D., Ph.D.
The Sidney Kimmel Comprehensive Cancer Center
James Pitaro
ESPN
Kevin Plank
Under Armour, Inc.
Buster Posey
San Francisco Giants
David Robinson
Admiral Capital Group
Sage Steele
ESPN
John W. Thiel
Merrill Lynch
Ciara Wilson
Grammy Award-Winning Singer/Songwriter
Russell Wilson
Denver Broncos
Rosa M. Gatti
ESPN, Inc.
Bob Lloyd
The V Foundation for Cancer Research